ACTIVE SUBSTANCE / INN

CICLOSPORIN

Brand name(s): Restaysis, Vekacia, Vevizye, Ikervis, Verkazia
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Conjunctivitis;Keratitis
Keratoconjunctivitis Sicca
ACTIVE SUBSTANCE
Ciclosporin
REGULATORS
EMA
SPONSORS / MAH
Allergan Pharmaceuticals International Limited, Laboratoires Théa, Santen Oy
TOTAL APPLICATIONS
5
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VerkaziaSanten OyAuthorised06/07/2018Conjunctivitis;Keratitis
IkervisSanten OyAuthorised19/03/2015Corneal Diseases
VevizyeLaboratoires ThéaAuthorised19/09/2024Keratoconjunctivitis Sicca
RestaysisAllergan Pharmaceuticals International LimitedApplication withdrawnDry Eye Syndromes
VekaciaNovagali Pharma S.A.Application withdrawnConjunctivitis, Allergic

FULL INTELLIGENCE ON CICLOSPORIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →